CytoDyn (CYDY) Dividends payables (2019 - 2026)
CytoDyn (CYDY) posted Dividends payables of $9.4 million for Q1 2026, up 4.04% on a QoQ basis from $9.0 million in Q4 2025, and up 18.72% year-over-year from $7.9 million in Q1 2025.
CytoDyn (CYDY) Dividends payables (2019 - 2026) Analysis & Trends
CytoDyn's Dividends payables history runs 8 years deep, the most recent figure standing at $9.4 million for Q1 2026.
- Quarterly Dividends payables rose 18.72% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $9.4 million (up 18.72% YoY) and the FY2025 annual result came in at $8.3 million, up 21.76% from the prior year.
- Dividends payables was $9.4 million for Q1 2026 at CytoDyn, up from $9.0 million in the prior quarter.
- Across five years, Dividends payables topped out at $9.4 million in Q1 2026 and bottomed at $3.6 million in Q1 2022.
- A 5-year average of $6.5 million and a median of $6.4 million in 2024 frame the typical range for Dividends payables.
- Annual changes were most pronounced in 2022 — Dividends payables surged 63.22% — and 2023, when it advanced 14.26%.
- CytoDyn's Dividends payables stood at $5.3 million in 2022, then climbed by 14.26% to $6.0 million in 2023, then grew by 24.52% to $7.5 million in 2024, then climbed by 19.64% to $9.0 million in 2025, then increased by 4.04% to $9.4 million in 2026.
- Business Quant data shows CYDY's Dividends payables at $9.4 million in Q1 2026, $9.0 million in Q4 2025, and $8.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CytoDyn | 267.79 Mn | 267.79 Mn | - | 9.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 9.38 Mn |
| Nov 30, 2025 | 9.01 Mn |
| Aug 31, 2025 | 8.64 Mn |
| May 31, 2025 | 8.27 Mn |
| Feb 28, 2025 | 7.90 Mn |
| Nov 30, 2024 | 7.53 Mn |
| Aug 31, 2024 | 7.16 Mn |
| May 31, 2024 | 6.79 Mn |
| Feb 29, 2024 | 6.42 Mn |
| Nov 30, 2023 | 6.05 Mn |
| Aug 31, 2023 | 5.68 Mn |
| May 31, 2023 | 5.31 Mn |
| Feb 28, 2023 | 5.42 Mn |
| Nov 30, 2022 | 5.29 Mn |
| Aug 31, 2022 | 4.36 Mn |
| May 31, 2022 | 3.98 Mn |
| Feb 28, 2022 | 3.64 Mn |
| Nov 30, 2021 | 3.48 Mn |
| Aug 31, 2021 | 3.07 Mn |
| May 31, 2021 | 2.65 Mn |